Korsana Biosciences, Inc. has announced the appointment of Matthew Leoni, M.D., as Chief Medical Officer and Gan Wei, Ph.D., as Chief Technical Officer. These appointments are part of the company's strategy to strengthen its leadership as it enters the next phase of growth.
Who to call at Korsana Biosciences, and when
A new leader at Korsana Biosciences brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Korsana Biosciences raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Korsana Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Korsana Biosciences. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Korsana Biosciences
Location
Waltham, Massachusetts, United States
About
Korsana Biosciences, Inc. is a biotechnology company focused on discovering and developing novel therapies for neurodegenerative diseases, particularly Alzheimer's disease. The company leverages its proprietary THETA™ therapeutic targeting platform to improve drug delivery and efficacy. Founded in 2024, Korsana aims to elevate patient care by creating potentially best-in-class therapeutics. The company's lead program, KRSA-028, targets amyloid beta and demonstrates strong preclinical data.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Korsana Biosciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.